Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Q3 2022 Program Management Update

31 Oct 2022 07:00

RNS Number : 5708E
R&Q Insurance Holdings Ltd
31 October 2022
 

 

R&Q Insurance Holdings Ltd

 

Q3 2022 Program Management Update

 

GWP grows by over 80% to $1.3 billion for the nine months ending 30 September 2022

 

31 October 2022

 

R&Q Insurance Holdings Ltd, (AIM-RQIH) ("R&Q"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, announces a performance update for its Program Management business for the nine months ending 30 September 2022.

 

Highlights

 

· Gross Written Premium ('GWP') of $1.3 billion (9m 2021: $714 million), an 83% increase

 

· Program Fee Income of $60 million (9m 2021: $30 million), a 100% increase1

 

William Spiegel, Executive Group Chairman, commented:

 

"Our Program Management business exhibited strong year-over-year growth as we continued to expand the depth and breadth of our MGA partnerships through the first nine months of 2022. Our team continues to find new and unique ways to meet the needs of our MGAs and reinsurance partners, as demonstrated in our recently announced multi-year transaction with Inperio. Additionally, I am pleased to report that our growth is broad-based with all three of our platforms (US Admitted, US Non-Admitted, and Europe) growing GWP and Fee Income. Looking forward, our pipeline of new MGA opportunities remains strong."

 

Notes:

1. Program Fee Income is on a written basis and excludes our share of earnings from minority stakes in MGAs.

 

Ends

 

Enquiries to:

 

R&Q Insurance Holdings Ltd

William Spiegel

Tel: 0207 780 5850

Tom Solomon

Tel: 0207 780 5850

Alan Quilter Tel: 020 7780 5960

 

Numis Securities Limited (Nominated Advisor and Joint Broker)

Giles Rolls 

Tel: 020 7260 1000

Charles Farquhar 

 

Barclays Bank PLC (Joint Broker)

Andrew Tusa

Anusuya Nayar Gupta

Tel: 020 7260 1000

 

 

Tel: 020 7632 2322

Tel: 020 7632 2322

FTI Consulting

Tom Blackwell

 

Tel: 020 3727 1051

 

 

 

Notes to Editors:

 

About R&Q 

 

R&Q is a global non-life specialty insurance company. We operate two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in their respective markets.

 

Our approach is to deploy our origination and underwriting capabilities, alongside our licensed and rated carriers in the US, EU and the UK, to generate attractive fee returns in Program Management and Legacy Insurance.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBKKBNDBDDFKN
Date   Source Headline
15th Jul 20208:01 amRNSBonus Share Issue and Total Voting Rights
9th Jul 20201:07 pmRNSResult of AGM
9th Jul 202012:00 pmRNSKen Randall Announces Retirement Date
26th Jun 20207:00 amRNSCaptive Acquisition
24th Jun 20204:41 pmRNSBonus Share Issue Ex-Entitlement Date
16th Jun 20209:31 amRNSDistribution of Annual Report & Accounts
15th Jun 20204:47 pmRNSNotice of Annual General Meeting
8th Jun 20204:36 pmRNSHolding(s) in Company
5th Jun 20207:00 amRNSAcquisition of NationsBuilders Insurance Company
4th Jun 20205:36 pmRNSHolding(s) in Company
4th Jun 20207:00 amRNSLoss Portfolio Transfer
1st Jun 20207:00 amRNSFinal results for the year ended 31 December 2019
29th May 20204:25 pmRNSResult of General Meeting
21st May 20207:00 amRNSAppointment of CFO
13th May 20207:00 amRNSBoard Appointment
7th May 20207:00 amRNSNotice of General Meeting and Posting of Circular
6th May 20203:51 pmRNSHolding(s) in Company
6th May 20207:00 amRNSHolding(s) in Company
6th May 20207:00 amRNSHolding(s) in Company
29th Apr 20207:00 amRNSSignificant new investment in the Group
24th Apr 20202:05 pmRNSTransaction in Own Shares
24th Apr 20207:00 amRNSLoss Portfolio Transfer
23rd Apr 20204:04 pmRNSTransaction in Own Shares
22nd Apr 20205:35 pmRNSTransaction in Own Shares
21st Apr 20203:00 pmRNSTransaction in Own Shares
17th Apr 20205:13 pmRNSTransaction in Own Shares
15th Apr 20205:34 pmRNSTransaction in Own Shares
14th Apr 20207:00 amRNSAcquisition of ICI Insurance Company Limited
23rd Mar 20205:59 pmRNSTransaction in Own Shares
19th Mar 20204:52 pmRNSTransaction in Own Shares
19th Mar 20207:00 amRNSPart VII Transfer
18th Mar 20205:17 pmRNSTransaction in Own Shares
17th Mar 20205:43 pmRNSTransaction in Own Shares
17th Mar 20207:00 amRNSAccredited announces new underwriting program
16th Mar 20204:30 pmRNSTransaction in Own Shares
16th Mar 20207:00 amRNSShare Repurchase Programme
13th Mar 20207:00 amRNSR&Q and UK P&I Club agree transfer of liabilities
11th Feb 20208:00 amRNSProgram underwriting partnership
30th Jan 20207:00 amRNSPortfolio transfer
27th Jan 20207:00 amRNSAcquisition
16th Jan 20207:00 amRNSDirector Dealings
15th Jan 20207:00 amRNSDirectorate Change
14th Jan 20207:00 amRNSAllotment of Shares
13th Jan 20207:00 amRNSAppointment of Executive Deputy Chairman
30th Dec 201911:05 amRNSAcquisition
23rd Dec 20199:18 amRNSHolding(s) in Company
3rd Dec 20197:00 amRNSBoard Update
22nd Nov 201910:36 amRNSHolding(s) in Company
22nd Nov 20197:00 amRNSProgram underwriting partnership
28th Oct 20197:00 amRNSProgram underwriting partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.